Is Omeros Corporation (OMER) a Buy, Sell, or Hold?
NASDAQ : OMER
Omeros Corporation — Institutional Ownership
$11.84 USD
-$0.09 (-0.75%)
- Volume
- 1.28M
- Average Volume
- 1.85M
- Market Capitalization
- $856.92M
- P/E Ratio
- 9.11
- Dividend Yield
- 0.00%
- Price Target
- $33.00
- Year High
- $17.65
- Year Low
- $3.44
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.03
Institutional Ownership Summary
Institutional Ownership %
0.86%
Investors Holding
29
change: -142 | last: 171
Increased Positions
12
change: -86 | last: 98
Reduced Positions
6
change: -33 | last: 39
New Positions
5
change: -30 | last: 35
Sold Positions
137
change: 106 | last: 31
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -91.4241 | last: 0.9142
Total Invested
5.9M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-23 | INGALLS & SNYDER LLC | 3.47M | 4.80% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-01-30 | The Vanguard Group | 4.01M | 5.66% |
| 2025-10-31 | The Vanguard Group | 3.35M | 4.91% |
| 2025-02-21 | INGALLS & SNYDER LLC | 4.16M | 7.20% |
| 2024-01-29 | (1) BlackRock, Inc. | 4.28M | 6.80% |
| 2022-07-08 | (1) BlackRock, Inc. | 1.23M | 2.00% |
| 2022-02-14 | Cormorant Asset Management, LP | - | 0.00% |
| 2022-02-14 | Cormorant Global Healthcare Master Fund, LP | - | 0.00% |
| 2022-02-14 | Bihua Chen | - | 0.00% |
| 2022-02-14 | Cormorant Global Healthcare GP, LLC | - | 0.00% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 3.36M | 5.37% |
| 2022-02-04 | 13-5156620 | 4.46M | 7.10% |
| 2022-02-03 | (1) BlackRock, Inc. | 4.05M | 6.50% |
| 2021-02-17 | Mitchell Blutt | - | 0.00% |
| 2021-02-17 | Consonance Capman GP LLC | - | 0.00% |
| 2021-02-17 | Consonance Capital Management LP | - | 0.00% |
| 2021-02-17 | Consonance Capital Opportunity Fund Management LP | - | 0.00% |
| 2021-02-16 | Bihua Chen | 5M | 8.10% |
| 2021-02-16 | Cormorant Global Healthcare Master Fund, LP | 4.8M | 7.80% |
| 2021-02-16 | Cormorant Global Healthcare GP, LLC | 4.8M | 7.80% |
| 2021-02-16 | Consonance Capital Management LP | - | 0.00% |
| 2021-02-16 | Mitchell Blutt | 6.06M | 9.99% |
| 2021-02-16 | Consonance Capital Opportunity Fund Management LP | 1.19M | 2.04% |
| 2021-02-16 | Cormorant Asset Management, LP | 5M | 8.10% |
| 2021-02-16 | Consonance Capman GP LLC | 6.06M | 9.99% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 3.19M | 5.18% |
| 2021-02-09 | 13-5156620 | 4.75M | 7.70% |
| 2021-01-29 | (1) BlackRock, Inc. | 5.38M | 8.70% |
| 2020-05-04 | Cormorant Global Healthcare GP, LLC | 2.84M | 5.20% |
| 2020-05-04 | Cormorant Global Healthcare Master Fund, LP | 2.84M | 5.20% |
| 2020-05-04 | Cormorant Asset Management, LP | 3M | 5.50% |
| 2020-05-04 | Bihua Chen | 3M | 5.50% |
| 2020-02-14 | Mitchell Blutt | 3.2M | 6.42% |
| 2020-02-14 | Consonance Capital Management LP | 2.98M | 6.00% |
| 2020-02-14 | Consonance Capital Opportunity Fund Management LP | 213K | 0.43% |
| 2020-02-14 | Consonance Capman GP LLC | 3.2M | 6.42% |
| 2020-02-14 | Gregory A. Demopulos, M.D. | 5M | 8.75% |
| 2020-02-07 | 13-5156620 | 5.03M | 9.39% |
| 2020-02-05 | (1) BlackRock, Inc. | 4.06M | 7.60% |
| 2019-05-10 | 13-3695715 | 2.46M | 5.00% |
| 2019-05-10 | David E. Shaw | 2.46M | 5.00% |
| 2019-02-13 | 8.96% † | 4.62M | 8.96% |
| 2019-02-06 | (1) BlackRock, Inc. | 3.99M | 8.10% |
| 2019-01-30 | 13-5156620 | 5.58M | 11.40% |
| 2018-02-14 | Cormorant Asset Management, LLC | 900K | 1.87% |
| 2018-02-14 | Cormorant Global Healthcare Master Fund, LP | 749.84K | 1.56% |
| 2018-02-14 | Cormorant Global Healthcare GP, LLC | 749.84K | 1.56% |
| 2018-02-14 | 8.4%2 | 42.4M | 8.40% |
| 2018-02-14 | Bihua Chen | 900K | 1.87% |
| 2018-02-09 | 13-5156620 | 5.71M | 11.90% |
| 2018-01-29 | (1) BlackRock, Inc. | 3.93M | 8.20% |
| 2017-11-07 | Cormorant Asset Management, LLC | 2.45M | 5.10% |
| 2017-11-07 | Cormorant Global Healthcare Master Fund, LP | 2.45M | 4.20% |
| 2017-11-07 | Cormorant Global Healthcare GP, LLC | 2.45M | 4.20% |
| 2017-11-07 | Bihua Chen | 2.45M | 5.10% |
| 2017-02-14 | Gregory A. Demopulos, M.D. | 3.83M | 8.40% |
| 2017-02-14 | Cormorant Global Healthcare GP, LLC | 821.44K | 1.90% |
| 2017-02-14 | Bihua Chen | 975K | 2.70% |
| 2017-02-14 | Cormorant Asset Management, LLC | 975K | 2.70% |
| 2017-02-14 | 13-5156620 | 5.1M | 11.87% |
| 2017-02-14 | Cormorant Global Healthcare Master Fund, LP | 821.44K | 1.90% |
| 2017-02-14 | Cormorant Global Healthcare GP, LLC | 821.44K | 1.90% |
| 2017-02-14 | Cormorant Asset Management, LLC | 975K | 2.70% |
| 2017-02-14 | Bihua Chen | 975K | 2.70% |
| 2017-02-14 | Cormorant Global Healthcare Master Fund, LP | 821.44K | 1.90% |
| 2017-01-25 | (1) BlackRock, Inc. | 3.23M | 7.50% |
| 2016-03-01 | 10.0%2 | 40.66M | 10.00% |
| 2016-02-11 | 9.7%2 | 39.2M | 9.70% |
| 2016-02-05 | 13-5156620 | 3.76M | 9.90% |
| 2016-01-27 | (1) BlackRock, Inc. | 2.55M | 6.70% |
| 2015-10-13 | 98-0557567 | 333.0 | 0.00% |
| 2015-09-28 | Cormorant Asset Management, LLC | 1.96M | 5.20% |
| 2015-09-28 | Cormorant Global Healthcare GP, LLC | 1.96M | 5.20% |
| 2015-09-28 | Cormorant Global Healthcare Master Fund, LP | 1.96M | 5.20% |
| 2015-09-28 | Bihua Chen | 1.96M | 5.20% |
| 2015-08-10 | 98-0557567 | 3.85M | 10.20% |
| 2015-02-06 | 13-5156620 | 2.35M | 6.90% |
| 2015-02-02 | (1) BlackRock, Inc. | 1.95M | 5.70% |
| 2015-01-16 | 10.1%2 | 36.62M | 10.10% |
| 2014-08-07 | (1) BlackRock, Inc. | 1.67M | 4.90% |
| 2014-04-01 | 13-5156620 | 1.72M | 5.10% |
| 2014-02-14 | Peter Kolchinsky | - | 0.00% |
| 2014-02-14 | RA Capital Healthcare Fund, L.P. | - | 0.00% |
| 2014-02-14 | RA Capital Management, LLC | - | 0.00% |
| 2014-02-12 | 10.4%2 | 33.32M | 10.40% |
| 2014-01-30 | (1) BlackRock, Inc. | 1.6M | 5.30% |
| 2013-07-11 | 13-5156620 | 1.29M | 4.30% |
| 2013-05-20 | RA Capital Healthcare Fund, L.P. | 1.99M | 6.70% |
| 2013-05-20 | Peter Kolchinsky | 2.95M | 9.90% |
| 2013-05-20 | RA Capital Management, LLC | 2.95M | 9.90% |
| 2013-04-11 | 13-5156620 | 1.32M | 5.10% |
| 2013-01-22 | Gregory A. Demopulos, M.D. | 3.06M | 11.10% |
| 2012-01-17 | Gregory A. Demopulos, M.D. | 2.78M | 11.80% |
| 2011-01-24 | Gregory A. Demopulos, M.D. | 2.69M | 11.80% |
OMER Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $17.18 | 63.51M | $1.09B | $9.66M | $239.14M | $1.32B |
| 2024-12-31 | $9.88 | 58.17M | $574.73M | $3.4M | $207.02M | $778.35M |
| 2023-12-31 | $3.27 | 62.74M | $205.16M | $7.1M | $361.58M | $559.64M |
| 2022-12-31 | $2.26 | 62.74M | $141.79M | $11.01M | $342.02M | $472.8M |
| 2021-12-31 | $6.43 | 62.34M | $400.87M | $100.81M | $347.84M | $647.9M |
| 2020-12-31 | $14.29 | 57.18M | $817.06M | $10.5M | $268.84M | $1.08B |
| 2019-12-31 | $14.09 | 49.52M | $697.79M | $3.08M | $194.04M | $888.74M |
| 2018-12-31 | $11.14 | 48.58M | $541.21M | $5.86M | $151.45M | $686.8M |
| 2017-12-31 | $19.43 | 45.54M | $884.83M | $3.39M | $84.61M | $966.04M |
| 2016-12-31 | $9.92 | 40.45M | $401.23M | $2.22M | $79.71M | $478.71M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10.56 | 71.92M | $759.45M | $1.91M | $310.63M | $1.07B |
| 2025-12-31 | $17.18 | 63.51M | $1.09B | $9.66M | $239.14M | $1.32B |
| 2025-09-30 | $4.10 | 66.26M | $271.68M | $2.4M | $191.61M | $460.9M |
| 2025-06-30 | $3.00 | 58.59M | $175.76M | $1.9M | $184.33M | $358.18M |
| 2025-03-31 | $8.22 | 58.06M | $477.22M | $4.26M | $415.05M | $888.01M |
| 2024-12-31 | $9.88 | 58.17M | $574.73M | $3.4M | $207.02M | $778.35M |
| 2024-09-30 | $3.97 | 57.95M | $230.05M | $1.52M | $209.47M | $438M |
| 2024-06-30 | $3.95 | 57.94M | $228.88M | $2.12M | $444.36M | $671.11M |
| 2024-03-31 | $3.19 | 58.8M | $187.57M | $1.83M | $472.15M | $657.89M |
| 2023-12-31 | $3.27 | 62.44M | $204.18M | $7.1M | $361.58M | $558.66M |
| 2023-09-30 | $2.92 | 62.86M | $183.54M | $30.64M | $340.87M | $493.78M |
| 2023-06-30 | $5.44 | 62.84M | $341.83M | $6.6M | $467.07M | $802.3M |